The programme-specific operating model for quality assurance of the FASP programme should be read in conjunction with the latest SQAS operating model and the relevant programme standards. Guidance is available on the FASP programme’s processes for ensuring seamless and safe screening across the whole pathway. Providers and commissioners should use these to ensure high quality and consistent screening services. PHE publishes the 20-week screening scan pathway requirements specification and the Down’s syndrome, Edwards’ syndrome and Patau’s syndrome screening pathway requirements specification, which provide an overview of FASP screening by describing what should happen at each stage of the end-to-end pathways. PHE also has terms of reference for NHS population screening programme RACs.Īll routine data requests (not research) should go via the PHE Screening helpdesk. Requests for screening data and researchĪll requests for access to FASP data for research purposes need to be approved by the antenatal and newborn screening research advisory committee (RAC).
#Fetal heartbeat doppler target how to#
Guidelines on handling patient information explain how to use and safeguard personal data in screening. Key performance indicator ( KPI) data reports are available for all 11 national screening programmes. PHE publishes a joint antenatal screening standards data report. PHE publishes reports setting out annual data collected from FASP. UK NSC recommendation on fetal anomaly screening in pregnancy UK NSC recommendation on Down’s syndrome screening in pregnancy Recommendations are based on internationally recognised criteria and a rigorous evidence review process. It ensures that screening provides more benefit than harm, at a reasonable cost to the NHS. The UK NSC makes recommendations to ministers in the 4 UK countries on all aspects of population screening. Evidence baseįASP is one of 11 NHS national population screening programmes available in England.
This could be:ĬVS and amniocentesis: information for parents explains more about these tests. Diagnostic testsĪ diagnostic test is offered where a woman has received a higher chance screening test result for Down’s syndrome and/or Edwards’ syndrome and Patau’s syndrome, and if there are unexpected findings at the time of the ultrasound scan. NIPT is now offered following a higher chance result (between 1 in 2 and 1 in 150) from either the combined or quadruple test in both singleton and twin pregnancies.įor more information, refer to the operational guidance on NIPT.įind out more about NIPT on the PHE Screening blog. NIPT has been added to the existing NHS screening pathway for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome as part of an evaluative rollout. Non-invasive prenatal screening test (NIPT) The private screening: important information leaflet provides information for people who ask about private screening options. The 20-week screening scan is offered to screen for Edwards’ syndrome and Patau’s syndrome, and 11 physical conditions. The quadruple test is offered in the second trimester to assess the chance of the baby having Down’s syndrome. The combined test is offered in the first trimester to assess the chance of the baby having Down’s syndrome, Edwards’ syndrome or Patau’s syndrome, and is the test of choice. The screening tests for you and your baby leaflet sets out the test process and purpose. Information is available for the conditions screened for in the 20-week scan:Ĭare pathways are available for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome screening, as well as for the 20-week scan. Scans can be completed up to 23⁺⁰ weeks of pregnancy. Screening for 11 physical conditions as part of the 20-week scan is offered to all pregnant women and takes place between 18⁺⁰ and 20⁺⁶ weeks of pregnancy. Screening for Edwards’ syndrome and Patau’s syndrome is offered to all eligible pregnant women and takes place between 10⁺⁰ and 14⁺¹ weeks of pregnancy. Screening for Down’s syndrome is offered to all eligible pregnant women, and takes place between 10⁺⁰ and 20⁺⁰ weeks of pregnancy. PHE has also published information about patient confidentiality in population screening programmes. Public Health England ( PHE) is committed to reducing inequalities and variation in participation to help make sure everyone has fair and equal access to screening services. The FASP handbook brings together national guidance, information and processes that relate to the FASP screening pathways. Information about the screening tests should be provided to each pregnant woman so she is able to make a personal informed choice about the tests.
0 kommentar(er)
